Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.
about
Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirinlncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic CancerEffects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsNaturally occurring compounds as pancreatic cancer therapeutics
P2860
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@en
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@nl
type
label
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@en
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@nl
prefLabel
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@en
Curcumin sensitizes pancreatic ...... nd the lncRNA PVT1 expression.
@nl
P2093
P2860
P356
P1433
P1476
Curcumin sensitizes pancreatic ...... and the lncRNA PVT1 expression
@en
P2093
Haiyong Han
Kazuhiro Yoshida
Preethi Ravindranathan
Shusuke Toden
P2860
P304
P356
10.1093/CARCIN/BGX065
P407
P50
P577
2017-10-01T00:00:00Z